Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
As a potent and selective oral inhibitor targeting FGFR subtypes 1/2/3, Pemigati···【more】
Release date：2024-08-13Recommended：161
Pemigatinib, brand name Damitan, is a potent and selective oral inhibitor agains···【more】
Release date：2024-08-13Recommended：146
Pemigatinibis a small molecule kinase inhibitor targeting the fibroblast growth ···【more】
Release date：2024-08-13Recommended：216
Pemigatinib is indicated for adult patients with advanced, metastatic, or unrese···【more】
Release date：2024-08-13Recommended：210
Pemigatinib is an innovative targeted therapy that provides a new treatment opti···【more】
Release date：2024-08-13Recommended：252
Pemigatinibis mainly used to treat specific diseases such as advanced or metasta···【more】
Release date：2024-08-13Recommended：243
Pemigatinib is used in adults to treat bile duct cancer that has spread to other···【more】
Release date：2024-08-13Recommended：216
Pemigatinib is a targeted therapy drug developed by Incyte in the United States,···【more】
Release date：2024-08-12Recommended：218
Venetoclax is a drug used to treat leukemias, specifically chronic lymphocytic l···【more】
Release date：2024-08-09Recommended：245
Venetoclax is a BCL-2 inhibitor that selectively binds to BCL-2 protein and inhi···【more】
Release date：2024-08-09Recommended：208
Pemigatinib is a potent and selective oral antineoplastic drug targeting the FGF···【more】
Release date：2024-08-09Recommended：179
Pemigatinib is a targeted drug for cholangiocarcinoma, which has been marketed i···【more】
Release date：2024-08-09Recommended：140
